About the journal
Saudi Pharmaceutical Journal is an open-access journal published by Springer in Switzerland, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 2,390 EUR. Declared review time at DOAJ: 12 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Springer
- ISSN
- 1319-0164 · 2213-7475
- Country
- Switzerland
- Languages
- english
- Access
- Open access
- Declared publication charge
- 2,390 EUR
- Articles in DOAJ
- 1914
- Declared review time
- 12 weeks
- Declared peer-review model
- double_blind
Index listings
- DOAJ · 2016-05-03
- PUBMED · 2022-01-19
- Indexing
- DOAJ · PUBMED
- APC
- 2,390 EUR
- Declared review time (DOAJ)
- 12 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
1914
Most recent article
last month
Average review time (journal-declared via DOAJ)
12weeks
Works in OpenAlex
2304
Last recorded publication year
2026
h-index
103
i10-index
1366
From OpenAlex open data (CC0).
Editorial & policy12
- Last DOAJ review date
- 2026-03-17
- Added to DOAJ
- 2016-05-03
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 96%
- ORCID iDs in current deposits
- 66%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 9705695
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Advanced Drug Delivery Systems
- Pharmaceutical Practices and Patient Outcomes
- Pharmaceutical Practices and Patient Outcomes
- Pharmacy and Medical Practices
- Drug Solubulity and Delivery Systems
- Pharmaceutical Practices and Patient Outcomes
- Medicinal Plant Research
- Advanced Drug Delivery Systems
Show all subjects (75)
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Drug Solubulity and Delivery Systems
- Nanoparticle-Based Drug Delivery
- Analytical Methods in Pharmaceuticals
- Human auditory perception and evaluation
- Diverse Scientific and Economic Studies
- Diverse Scientific and Economic Studies
- Human auditory perception and evaluation
- Diverse Specialized Academic Research
- Diverse Specialized Academic Research
- Synthesis and biological activity
- Pharmacovigilance and Adverse Drug Reactions
- Advancements in Transdermal Drug Delivery
- Pharmacovigilance and Adverse Drug Reactions
- Pharmacovigilance and Adverse Drug Reactions
- Essential Oils and Antimicrobial Activity
- Essential Oils and Antimicrobial Activity
- Advancements in Transdermal Drug Delivery
- Advancements in Transdermal Drug Delivery
- Computational Drug Discovery Methods
- Antibiotic Use and Resistance
- Antibiotic Use and Resistance
- Computational Drug Discovery Methods
- Medication Adherence and Compliance
- Medication Adherence and Compliance
- Analytical Methods in Pharmaceuticals
- Analytical Methods in Pharmaceuticals
- Synthesis and biological activity
- Synthesis and biological activity
- Phytochemistry and Biological Activities
- Pharmaceutical studies and practices
- Pharmaceutical studies and practices
- Pharmaceutical studies and practices
- Computational Drug Discovery Methods
- Patient Safety and Medication Errors
- Natural Antidiabetic Agents Studies
- Pharmacogenetics and Drug Metabolism
- Patient Safety and Medication Errors
- Patient Safety and Medication Errors
- Essential Oils and Antimicrobial Activity
- Antibiotic Use and Resistance
- Natural product bioactivities and synthesis
- Natural Antidiabetic Agents Studies
- Natural Antidiabetic Agents Studies
- Natural product bioactivities and synthesis
- Synthesis and Characterization of Heterocyclic Compounds
- Pharmacological Effects of Natural Compounds
- Nanoparticle-Based Drug Delivery
- Complementary and Alternative Medicine Studies
- Nanoparticle-Based Drug Delivery
- Pharmacological Effects of Natural Compounds
- Antibiotics Pharmacokinetics and Efficacy
- Drug-Induced Hepatotoxicity and Protection
- Antibiotics Pharmacokinetics and Efficacy
- Innovations in Medical Education
- Drug-Induced Hepatotoxicity and Protection
- Phytochemistry and Biological Activities
- Phytochemical Studies and Bioactivities
- Pharmaceutical Economics and Policy
- Pharmaceutical Economics and Policy
- Phytochemistry and Biological Activities
- Pharmaceutical Economics and Policy
- Inhalation and Respiratory Drug Delivery
- Pharmaceutical Quality and Counterfeiting
- Pharmaceutical Quality and Counterfeiting
- Pharmaceutical Quality and Counterfeiting
Keywords (DOAJ)
- medicinal chemistry
- structure based drug design
- drug target
- medicinal research
- pharmaceutical biotechnology
- pharmaceutical chemistry
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ